ODURep’s production of William Shakespeare’s “The Tempest,” directed by Chris Hanna, opened on Apr. 10. A culmination of a ...

"Too Darn Hot," directed by Kasey Viani, celebrates Hollywood's Greatest Hits, premiering at The Old Globe this Friday.

The Center for Teaching and Learning is putting on productions of “Twelfth Night” and “The Tempest” on Wednesday, April 16. Students in CTL’s middle school, grades 5-8, have been hard at work learning ...

Two River Theater has revealed its 2025/2026 Season. The season will commence in September with the World Premiere of Agatha Christie’s Murder on the Links, stylishly reimagined by Director Darko ...

This production, directed by Ola Ince, represents the first time a modern classic has been staged in the Globe Theatre. The play explores the events in Salem, Massachusetts in 1692, and draws ...

World Theatre Day 2025: Today, on Thursday, March 27, 2025, individuals around the world are observing World Theatre Day. It is an annual celebration that highlights the importance of theatres as a ...

March 27, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight ...

said choreographer Jackie Davis brings “the tempest, the actual storm, to life.” The production is being directed by Christie Vela. Hernández said that doing a monthlong run in one theater ...

For Closure! by acclaimed playwright Hannah Benitez arrives on the freeFall stage for its world premiere on April 11. This ...

He seems determined to keep missing it. He noted that The Globe and Mail’s story had made clear that the Canadian Security Intelligence Service had no evidence that Mr. Poilievre knew of India ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with ...